YUMC Q1 2026 Earnings EPS Misses Estimates Stock Edges Lower Lisata Therapeutics Q3 2025 Earnings NarrowerthanExpected Loss as Biotech Advances Clinical Pipeline IPW Q3 2025 Earnings Narrow Loss Misses Estimates Stock Rises on Resilience KEQU Q1 2026 Earnings Profitability Achieved with EPS of 028 EYPT Q1 2026 Earnings WiderthanExpected Loss as PreCommercial Biotech Continues RD Investment PSIX Q1 2026 Earnings EPS Falls Short of Estimates by Over 52